Expression of ADAMTS-5 in deformed human temporomandibular joint discs

Histology and Histopathology

Volumn 23, Issue 12, 2008, Pages 1485-1493

  Matsumoto, Takashi ^a   Tojyo, Itaru ^a   Kiga, Norifumi ^a   Hiraishi, Yukihiro ^a   Fujita, Shigeyuki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

ADAMTS 5; Aggrecanase; Human; Hypoxia; Temporomandibular joint disc

Indexed keywords

ADAM PROTEIN; COLLAGENASE; INTERLEUKIN 1BETA; MESSENGER RNA; OXYGEN; PROTEIN ADAMTS 5; THROMBOSPONDIN; THROMBOSPONDIN 5; UNCLASSIFIED DRUG; ADAMTS5 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; ARTICULAR CARTILAGE; CELL CULTURE; CELL HYPOXIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; MALE; MANDIBLE CONDYLE; OSTEOARTHRITIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TEMPOROMANDIBULAR JOINT DISORDER; BIOSYNTHESIS; CELL LINE; GENE EXPRESSION; METABOLISM; MIDDLE AGED; MYOFASCIAL PAIN; TEMPOROMANDIBULAR JOINT;

ADAM PROTEINS; ADULT; AGED; CELL LINE; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OSTEOARTHRITIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TEMPOROMANDIBULAR JOINT DISK; TEMPOROMANDIBULAR JOINT DISORDERS; TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME;

EID: 58149289762     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Adams J.C. and Hamblen D.L. (2001). Internal derangements of joints. In: Outline of orthopedics. 13th ed. Adams J.C. and Hamblen D.L. (eds). Churchill Livingstone. Edinburgh. pp 135.
2. Arner E.C., Pratta M.A., Trzaskos J.M., Decicco C.P. and Tortorella M.D. (1999). Generation and characterization of aggrecanase. A soluble, cartilage-derived aggrecan-degrading activity. J. Biol. Chem. 274, 6594-6601.
3. Bell W.E. (1990). Inflammatory disorders. In: Temporomandibular disorders. Classification, diagnosis, management. 3rd ed. Bell W.E. (ed). Year Book Medical Pub. Chicago. pp 339-357.
4. Benya P. and Shaffer J. (1982). Dedifferentiated chondrocytes re-express the differentiated collagen phenotype when cultured in agarose gels. Cell 30, 215-224.
5. Cernanec J., Guilak F., Weinberg J.B., Pisetsky D.S. and Fermor B. (2002). Influence of hypoxia and reoxygenation on cytokine-induced production of proinflammatory mediators in articular cartilage. Arthritis. Rheum. 46, 968-975.
6. De Bont L.G. and Stegenga B. (1993). Pathology of temporomandibular joint internal derangement and osteoarthrosis. Int. J. Oral. Maxillofac. Surg. 22, 71-74.
7. Giatromanolaki A., Sivridis E., Maltezos E., Athanassou N., Papazoglou D., Gatter K.C., Harris A.L. and Koukourakis M.I. (2003). Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis. Arthritis. Res. Ther. 5, 193-201.
8. Glasson S.S., Askew R., Sheppard B., Carito B., Blanchet T., Ma H.L., Flannery C.R., Peluso D., Kanki K., Yang Z., Majumdar M.K. and Morris E.A. (2005). Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434, 644-648.
9. Han M.K., Kim J.S., Park B.H., Kim J.R., Hwang B.Y., Lee H.Y., Song E.K. and Yoo W.H. (2003). NF-kappaB-dependent lymphocyte hyperadhesiveness to synovial fibroblasts by hypoxia and reoxygenation: potential role in rheumatoid arthritis. J. Leukoc. Biol. 73, 525-529.
10. Kaneyama K., Segami N., Nishimura M., Suzuki T. and Sato J. (2002). Importance of proinflammatory cytokines in synovial fluid from 121 joints with temporomandibular disorders. Br. J. Oral Maxillofac. Surg. 40, 418-423.
11. Kaplan A.S. (1991). Classification. In: Temporomandibular disorders. Diagnosis and treatment. 1st ed. Kaplan A.S. and Assael L.A. (eds). W.B. Saunders. Philadelphia. pp 106-117.
12. Kubota E., Imamura H., Kubota T., Shibata T. and Murakami K. (1997). Interleukin 1 beta and stromelysin (MMP3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint. J. Oral Maxillofac. Surg. 55, 20-27.
13. Kubota E., Kubota T., Matsumoto J., Shibata T. and Murakami K.I. (1998). Synovial fluid cytokines and proteinases as markers of temporomandibular joint disease. J. Oral. Maxillofac. Surg. 56, 192-198.
14. Kuno K., Okada Y., Kawashima H., Nakamura H., Miyasaka M., Ohno H. and Matsushima K. (2000). ADAMTS-1 cleaves a cartilage proteoglycan, aggrecan. FEBS Lett. 478, 241-245.
15. Martin G., Andriamanalijaona R., Grassel S., Dreier R., Mathy-Hartert M., Bogdanowicz P., Boumediene K., Henrotin Y., Bruckner P. and Pujol J.P. (2004). Effect of hypoxia and reoxygenation on gene expression and response to interleukin-1 in cultured articular chondrocytes. Arthritis. Rheum. 50, 3549-3560.
16. McCain J.P., Sanders B., Koslin M.G., Quinn J.D., Peters P.B. and Indresano T. (1992). Temporomandibular joint arthroscopy: a 6-year multicenter retrospective study of 4,831 joints. J. Oral Maxillofac. Surg. 50, 926-930.
17. Milam S.B. and Schmitz J.P. (1995). Molecular biology of temporomandibular joint disorders: proposed mechanisms of disease. J. Oral Maxillofac. Surg. 53, 1448-1454.
18. Nagase H. and Kashiwagi M. (2003). Aggrecanases and cartilage matrix degradation. Arthritis. Res. Ther. 5, 94-103.
19. Nitzan D.W. (1994). Intraarticular pressure in the functioning human temporomandibular joint and its alteration by uniform elevation of the occlusal plane.J. Oral Maxillofac. Surg. 52, 671-679.
20. Okeson J.P. (1996). Differential diagnosis and management considerations of temporomandibular disorders. In: Orofacial pain guidelines for assessment, diagnosis, and management. 3rd ed. Okeson J.P. (ed). Quintessence Publishing. Chicago. pp 113-158.
21. Pelletier J.P., Boileau C., Boily M., Brunet J., Mineau F., Geng C., Reboul P., Laufer S., Lajeunesse D. and Martel-Pelletier J. (2005). The protective effect of licofelone on experimental osteoarthritis is correlated with the downregulation of gene expression and protein synthesis of several major cartilage catabolic factors: MMP-13, cathepsin K and aggrecanases. Arthritis Res. Ther. 7, 1091-1102.
22. Sanders B. (1986). Arthroscopic surgery of the temporomandibular joint: treatment of internal derangement with persistent closed lock. Oral. Surg. Oral. Med. Oral. Pathol. 62, 361-372.
23. Semenza G.L. (2001). Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends. Mol. Med. 7, 345-350.
24. Shinoda C. and Takaku S. (2000). Interleukin-1beta, interleukin-6, and tissue inhibitor of metalloproteinase-1 in the synovial fluid of the temporomandibular joint with respect to cartilage destruction. Oral. Dis. 6, 383-390.
25. Stanton H., Rogerson F.M., East C.J., Golub S.B., Lawlor K.E., Meeker C.T., Little C.B., Last K., Farmer P.J., Campbell I.K., Fourie A.M. and Fosang A.J. (2005). ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 434, 648-652.
26. Stegenga B. (1996). Temporomandibular joint degenerative diseases: clinical diagnosis. In: Management of temporomandibular joint degenerative diseases biologic basis and treatment outcome. 1st ed. Stegenga B. and De Bont L.G.M. (eds). Birkhäuser. Basel. pp 13-24.
27. Stegenga B. (2001). Osteoarthritis of the temporomandibular joint organ and its relationship to disc displacement. J. Orofac. Pain 15, 193-205.
28. Suzuki T., Segami N., Kaneyama K., Nishimura M. and Nojima T. (1999). Specific expression of interleukin-1 beta in temporomandibular joints with internal derangement: correlation with clinical findings. Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod. 88, 413-417.
29. Takahashi T., Kondoh T., Fukuda M., Yamazaki Y., Toyosaki T. and Suzuki R. (1998). Proinflammatory cytokines detectable in synovial fluids from patients with temporomandibular disorders. Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod. 85, 135-141.
30. Takigawa T., Fujita S., Koyama M. and Iizuka T. (1992). Immunohistochemical study of localization of the extracellular matrix on the articular disc of human adult temporomandibular joint. Jpn. J. Oral Maxillofac. Surg. 38, 863-871.
31. Tang B.L. (2001). ADAMTS: a novel family of extracellular matrix proteases. Int. J. Biochem. Cell. Biol. 33, 33-44.
32. Tortorella M.D., Burn T.C., Pratta M.A., Abbaszade I., Hollis J.M., Liu R., Rosenfeld S.A., Copeland R.A., Decicco C.P., Wynn R., Rockwell A., Yang F., Duke J.L., Solomon K., George H., Bruckner R., Nagase H., Itoh Y., Ellis D.M., Ross H., Wiswall B.H., Murphy K., Hillman M.C. Jr, Hollis G.F., Newton R.C., Magolda R.L., Trzaskos J.M. and Arner E.C. (1999). Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science 284, 1664-1666.
33. Vincenti M.P. and Brinckerhoff C.E. (2001). Early response genes induced in chondrocytes stimulated with the inflammatory cytokine interleukin-1beta. Arthritis. Res. 3, 381-388.
34. Wiesener M.S., Turley H., Allen W.E., Willam C., Eckardt K.U., Talks K.L., Wood S.M., Gatter K.C., Harris A.L., Pugh C.W., Ratcliffe P.J. and Maxwell P.H. (1998). Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1 alpha. Blood 92, 2260-2268.
35. Yamaguchi A., Tojyo I., Yoshida H. and Fujita S. (2005). Role of hypoxia and interleukin-1beta in gene expressions of matrix metalloproteinases in temporomandibular joint disc cells. Arch. Oral. Biol. 50, 81-87.
36. Yoshida H., Yoshida T., Iizuka T., Sakakura T. and Fujita S. (1999). The localization of matrix metalloproteinase-3 and tenascin in synovial membrane of the temporomandibular joint with internal derangement. Oral Dis. 5, 50-54.
37. Yoshida K., Takatsuka S., Tanaka A., Hatada E., Nakamura H., Nakagawa K. and Okada Y. (2005). Aggrecanase analysis of synovial fluid of temporomandibular joint disorders. Oral Dis. 11, 299-302.